Remedy Open Access 1, article 1003, 2016. Breast Cancer Res Treat 64:97, 2000. Ann Nucl Med 29:138-148, 2015. Ann Nucl Med 29:138-148, 2015. Selected for This Month in Investigative Urology. What breast cancer patients benefit from staging bone scintigraphy? Jpn J Clin Oncol 31: 263-269, 2001. Clinical Nuclear Medicine, 43, 365-366, 2018. BJU International 87:348-351, 2001. Annals of Nuclear Medicine 32, 105-113, 2018. Annals of Nuclear Medicine 32, 105-113, 2018. Impending Atypical Femoral Fracture in a Patient of Breast Cancer with Bone Metastases Receiving Long-Term Denosumab. European J Cancer 34:230-239, 1998. European J Cancer 34:230-239, 1998. Jpn J Clin Oncol 31: 263-269, 2001. Breast Cancer Res Treat 64:97, 2000. Impending Atypical Femoral Fracture in a Patient of Breast Cancer with Bone Metastases Receiving Long-Term Denosumab. BJU International 87:348-351, 2001. Ann Nucl Med 31,719-725, 2017. Clinical Nuclear Medicine, 43, 365-366, 2018. Ann Nucl Med 16:161-168, 2002. Selected for This Month in Investigative Urology. Karsdal: Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers. Remedy Open Access 1, article 1003, 2016. What breast cancer patients benefit from staging bone scintigraphy? Karsdal: Serum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers. Ann Nucl Med 16:161-168, 2002. Ann Nucl Med 31,719-725, 2017.。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。